Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Drandi · SciRah

Researcher profile · Semantic Scholar

D. Drandi

Share profile

D. Drandi — researcher profile on SciRah

h-index: 26
Works: 168
Citations: 3,103

Most-cited papers

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
M. Ladetto, M. Brüggemann, L. Monitillo, S. Ferrero +13 more
2014Leukemia299 citations Open access
Semantic Scholar
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.
D. Drandi, Lenka Kubiczkova-Besse, S. Ferrero, N. Dani +17 more
2015Journal of Molecular Diagnostics124 citations Open access
Semantic Scholar
Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival
S. Ferrero, M. Ladetto, D. Drandi, F. Cavallo +21 more
2014Leukemia89 citations Open access
Semantic Scholar
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia
D. Drandi, E. Genuardi, I. Dogliotti, M. Ferrante +17 more
2018Haematologica79 citations Open access
Semantic Scholar
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
M. Coscia, C. Vitale, S. Peola, M. Foglietta +15 more
2012Blood59 citations Open access
Semantic Scholar
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
I. Dogliotti, C. Jiménez, M. Varettoni, D. Talaulikar +26 more
2022Leukemia48 citations Open access
Semantic Scholar
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network
D. Drandi, M. Alcantara, I. Benmaad, Arian Söhlbrandt +23 more
2020HemaSphere44 citations Open access
Semantic Scholar
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells
M. Rigoni, C. Riganti, C. Vitale, V. Griggio +11 more
2015OncoTarget44 citations Open access
Semantic Scholar
Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma
M. Ladetto, Simone Ferrero, D. Drandi, M. Festuccia +16 more
2014Leukemia37 citations Open access
Semantic Scholar
Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis
S. Oliva, M. Gambella, M. Gilestro, V. Muccio +19 more
2016OncoTarget36 citations Open access
Semantic Scholar
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma
S. Ferrero, Daniele Grimaldi, E. Genuardi, D. Drandi +22 more
2022Blood29 citations Open access
Semantic Scholar
Droplet Digital PCR for Minimal Residual Disease Detection in Mature Lymphoproliferative Disorders.
D. Drandi, S. Ferrero, M. Ladetto
2018Methods in molecular biology28 citations
Semantic Scholar
New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies
I. Dogliotti, D. Drandi, E. Genuardi, S. Ferrero
2018Journal of Clinical Medicine25 citations Open access
Semantic Scholar
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi
F. Zaja, S. Ferrero, C. Stelitano, A. Ferrari +18 more
2017Haematologica25 citations Open access
Semantic Scholar
MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients
A. Rocci, M. Gambella, S. Aschero, I. Baldi +19 more
2014British Journal of Haematology24 citations Open access
Semantic Scholar
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma
S. Ferrero, L. Monitillo, B. Mantoan, D. Barbero +15 more
2013Annals of Hematology21 citations
Semantic Scholar
Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
R. García-Sanz, M. Varettoni, C. Jiménez, S. Ferrero +18 more
2023Seminars in hematology (Print)19 citations Open access
Semantic Scholar
MYD88L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation
M. Ferrante, D. Furlan, S. Zibellini, M. Borriero +17 more
2021Diagnostics18 citations Open access
Semantic Scholar
Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up
M. Parisi, I. Dogliotti, M. Clerico, Davide Bertuzzo +14 more
2022European Journal of Neurology17 citations Open access
Semantic Scholar
Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma
C. Lobetti‐Bodoni, B. Mantoan, L. Monitillo, E. Genuardi +5 more
2013Therapeutic Advances in Hematology17 citations Open access
Semantic Scholar
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes
S. Ferrero, D. Capello, M. Svaldi, M. Boi +21 more
2012Haematologica17 citations Open access
Semantic Scholar
Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports
Simona Elba, A. Castellino, Roberto Soriasio, C. Castellino +12 more
2020Journal of Medical Case Reports15 citations Open access
Semantic Scholar
Minimal residual disease (MRD) in non‐Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network
I. Della Starza, M. Cavalli, L. A. De Novi, E. Genuardi +18 more
2019Hematological Oncology14 citations
Semantic Scholar
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia
V. Griggio, G. Mandili, C. Vitale, M. Capello +15 more
2016OncoTarget14 citations Open access
Semantic Scholar
Comprehensive Minimal Residual Disease (MRD) Analysis of the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial for Younger Patients with Mantle Cell Lymphoma: A Kinetic Model Ensures a More Refined Risk Stratification
S. Ferrero, Barbero Daniela, Mariella Lo Schirico, A. Evangelista +23 more
2018Blood11 citations
Semantic Scholar
Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma
Antonio Matera, A. Marella, A. Maeda, M. da Via +14 more
2022International Journal of Molecular Sciences10 citations Open access
Semantic Scholar
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial
G. Zaccaria, S. Ferrero, E. Hoster, R. Passera +25 more
2021Cancers10 citations Open access
Semantic Scholar
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.
C. Lobetti‐Bodoni, D. Ferrero, E. Genuardi, R. Passera +21 more
2012Mechanisms of Ageing and Development9 citations Open access
Semantic Scholar
Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights
C. Salvetti, C. Vitale, V. Griggio, D. Drandi +10 more
2022Frontiers in Oncology8 citations Open access
Semantic Scholar
Ficoll‐hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis
E. Genuardi, D. Barbero, Irene Dogliotti, B. Mantoan +17 more
2018International Journal of Laboratory Hematology8 citations
Semantic Scholar
Minimal Residual Disease Analysis by Monitoring Immunoglobulin and T-Cell Receptor Gene Rearrangements by Quantitative PCR and Droplet Digital PCR.
I. Della Starza, C. Eckert, D. Drandi, G. Cazzaniga
2022Methods in molecular biology7 citations Open access
Semantic Scholar
Nucleic Acid Biomarkers in Waldenström Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance
D. Drandi, Philippe Decruyenaere, M. Ferrante, F. Offner +2 more
2022Diagnostics7 citations Open access
Semantic Scholar
Cell-Free DNA for Minimal Residual Disease Monitoring in Multiple Myeloma Patients
L. Besse, D. Drandi, L. Sedlaříková, S. Oliva +8 more
20147 citations
Semantic Scholar
Next-Generation Sequencing and Real-Time Quantitative PCR for Minimal Residual Disease (MRD) Detection Using the Immunoglobulin Heavy Chain Variable Region: A Methodical Comparison in Acute Lymphoblastic Leukemia (ALL), Mantle Cell Lymphoma (MCL) and Multiple Myeloma (MM)
M. Ladetto, M. Brüggemann, S. Ferrero, F. Pépin +9 more
20127 citations
Semantic Scholar
Long‐term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients
R. Tavarozzi, Simone Ferrero, A. Evangelista, E. Genuardi +27 more
2025HemaSphere6 citations Open access
Semantic Scholar
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study.
C. Visco, V. Tabanelli, M. Sacchi, A. Evangelista +39 more
2025The Lancet Haematology6 citations Open access
Semantic Scholar
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial.
A. Pulsoni, Simone Ferrero, M. Tosti, S. Luminari +44 more
2024The Lancet Haematology6 citations
Semantic Scholar
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study
E. Iannitto, Simone Ferrero, C. Bommier, D. Drandi +28 more
2024Haematologica6 citations Open access
Semantic Scholar
MYD88 L265P Mutation Detection by ddPCR: Recommendations for Screening and Minimal Residual Disease Monitoring : ddPCR for Highly Sensitive Detection of MYD88 L265P Mutation.
D. Drandi, M. Ferrante, M. Borriero, S. Ferrero
2023Methods in molecular biology6 citations
Semantic Scholar
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma
E. Genuardi, P. Klous, B. Mantoan, D. Drandi +20 more
2021Hematological Oncology6 citations Open access
Semantic Scholar
Dysfunctional V 9 V 2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells *
M. Coscia, C. Vitale, S. Peola, M. Foglietta +15 more
20126 citations
Semantic Scholar
Efficacy and safety of bendamustine, rituximab and bortezomib treatment in relapsed/refractory Waldenstrom Macroglobulinaemia: results of phase 2 single‐arm FIL‐BRB trial
G. Benevolo, D. Drandi, Nicoletta Villiva', Anna Castiglione +21 more
2024British Journal of Haematology5 citations Open access
Semantic Scholar
Treatment of Relapsed/Refractory Waldenström Macroglobulinemia Patients: Final Clinical and Molecular Results of the Phase II Brb (Bendamustine, Rituximab and Bortezomib) Trial of the Fondazione Italiana Linfomi (FIL)
G. Benevolo, S. Ferrero, Nicoletta Villiva', A. Castiglione +22 more
2021Blood5 citations Open access
Semantic Scholar
FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY
Simone Ferrero, M. Ladetto, K. Beldjord, D. Drandi +21 more
2019Hematological Oncology5 citations
Semantic Scholar
Bortezomib in Combination with Ibrutinib/Rituximab Is a Highly Effective and Well Tolerated First - Line Treatment for Waldenström's Macroglobulinemia: Results of the Multicenter Phase II trial (ECWM-2) of the European Consortium for Waldenström's Macroglobulinemia
C. Buske, E. Kastritis, Alexander Grunenberg, A. Viardot +23 more
2024Blood4 citations
Semantic Scholar
Prospective Evaluation of Minimal Residual Disease in Waldenström Macroglobulinemia across Different Tissues and Treatments: Results of the “BIO-WM” Trial of the Fondazione Italiana Linfomi (FIL)
M. Ferrante, D. Drandi, S. Zibellini, L. Marcheselli +26 more
2023Blood4 citations Open access
Semantic Scholar
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma
I. Della Starza, L. A. De Novi, M. Cavalli, N. Novelli +21 more
2020Hematological Oncology4 citations
Semantic Scholar
Targeted Locus Amplification (TLA): A Novel Next Generation Sequencing (NGS) Technology to Detect New Molecular Markers and Monitoring Minimal Residual Disease (MRD) in Mantle Cell and Follicular Lymphoma
E. Genuardi, P. Klous, D. Drandi, B. Mantoan +16 more
20174 citations
Semantic Scholar
Minimal Residual Disease Monitoring During Maintenance In Multiple Myeloma Patients
M. Gambella, P. Omede', D. Drandi, F. Patriarca +19 more
20134 citations
Semantic Scholar
Molecular remission is an independent predictor of progression‐free survival in patients with Waldenström macroglobulinemia treated with chemo‐immunotherapy: Results from the FIL_BIOWM study
M. Varettoni, S. Zibellini, M. Merli, D. Drandi +15 more
2022Hematological Oncology3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Ladetto×26
Invite
M. Ladetto — researcher profile on SciRah
E. Genuardi×20
Invite
E. Genuardi — researcher profile on SciRah
M. Boccadoro×19
Invite
M. Boccadoro — researcher profile on SciRah
M. Ferrante×15
Invite
M. Ferrante — researcher profile on SciRah

×14

Invite

S. Ferrero — researcher profile on SciRah

Invite

S. Ferrero — researcher profile on SciRah

Invite

B. Mantoan — researcher profile on SciRah

Invite

R. Passera — researcher profile on SciRah

L. Monitillo×10

Invite

L. Monitillo — researcher profile on SciRah

S. Cortelazzo×10

Invite

S. Cortelazzo — researcher profile on SciRah

Invite

D. Barbero — researcher profile on SciRah

Invite

A. Palumbo — researcher profile on SciRah